Diagnóstico y tratamiento | 03 MAR 20

Compresión medular metastásica

Revisión de las causas y presentaciones de la compresión medular metastásica
INDICE:  1. Página 1 | 2. Página 2
Página 2

Referencias

1 McCurdy MT, Shanholtz CB. Oncologic emergencies. Crit Care Med 2012;40:2212-22. doi:10.1097/CCM.0b013e31824e1865 pmid:22584756.
2 Prasad D, Schiff D. Malignant spinal-cord compression. Lancet Oncol 2005;6:15-24. doi:10.1016/S1470-2045(05)70022-X pmid:15629272.
3 Loblaw DA, Mitera G, Ford M, Laperriere NJA. A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. Int J Radiat Oncol Biol Phys 2012;84:312-7. doi:10.1016/j.ijrobp.2012.01.014 pmid:22420969.
 4 Bucholtz JD. Metastatic epidural spinal cord compression. Semin Oncol Nurs 1999;15:150-9. doi:10.1016/S0749-2081(99)80002-3 pmid:10461699.
5 Levack P, Graham J, Collie D, et al. A prospective audit of the diagnosis, management and outcome of malignant spinal cord compression. Clinical Resource and Audit Group, 2001.
6 National Institute for Health and Care Excellence. Metastatic spinal cord compression: diagnosis and management of patients at risk of or with metastatic spinal cord compression. Full guideline. 2008. www.nice.org.uk/guidance/cg75/evidence/full-guideline-242052589.
7 Savage P, Sharkey R, Kua T, et al. Malignant spinal cord compression: NICE guidance, improvements and challenges. QJM 2014;107:277-82. doi:10.1093/qjmed/hct244 pmid: 24336849.
8 Levack P, Graham J, Collie D, et al. Scottish Cord Compression Study Group. Don’t wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression. Clin Oncol (R Coll Radiol) 2002;14:472-80. doi:10.1053/clon.2002.0098 pmid:12512970.
9 Loblaw DA, Laperriere NJ, Mackillop WJ. A population-based study of malignant spinal cord compression in Ontario. Clin Oncol (R Coll Radiol) 2003;15:211-7. doi:10.1016/S0936-6555(02)00400-4 pmid:12846501.
10 Ribas ES, Schiff D, Schiff D. Spinal cord compression. Curr Treat Options Neurol 2012;14:391-401. doi:10.1007/s11940-012-0176-7 pmid:22547256.
11 Rades D, Blach M, Nerreter V, Bremer M, Karstens JH. Metastatic spinal cord compression. Influence of time between onset of motoric deficits and start of irradiation on therapeutic effect. Strahlenther Onkol 1999;175:378-81. doi:10.1007/s000660050024 pmid:10481768.
12 Abrahm JL. Assessment and treatment of patients with malignant spinal cord compression. J Support Oncol 2004;2:377-88, 391, discussion 391-3, 398, 401.pmid:15524067.
13 Li KC, Poon PY. Sensitivity and specificity of MRI in detecting malignant spinal cord compression and in distinguishing malignant from benign compression fractures of vertebrae. Magn Reson Imaging 1988;6:547-56. doi:10.1016/0730-725X(88)90129-4 pmid:3067022.
14 Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol 2005;23:2028-37. doi:10.1200/JCO.2005.00.067 pmid:15774794.
15 Klimo P Jr, , Kestle JR, Schmidt MH. Treatment of metastatic spinal epidural disease: a review of the literature. Neurosurg Focus 2003;15:E1. doi:10.3171/foc.2003.15.2.12 pmid: 15323458.
16 L’Espérance S, Vincent F, Gaudreault M, et al. Comité de l’évolution des pratiques en oncologie. Treatment of metastatic spinal cord compression: cepo review and clinical recommendations. Curr Oncol 2012;19:e478-90. doi:10.3747/co.19.1128 pmid:23300371.
17 Sørensen S, Helweg-Larsen S, Mouridsen H, Hansen HH. Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1994;30A:22-7. doi:10.1016/S0959-8049(05)80011-5 pmid:8142159.
18 Vecht CJ, Haaxma-Reiche H, van Putten WLJ, de Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high-dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39:1255-7. doi:10.1212/WNL.39.9.1255 pmid:2771077.
19 Greenberg HS, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor: results with a new treatment protocol. Ann Neurol 1980;8:361-6. doi:10.1002/ana. 410080404 pmid:7436380.
20 Murray-Brown F. Steroid use for patients with brain metastases and spinal cord compression. Clin Med (Lond) 2015;15:108.pmid:25650220.
21 Heimdal K, Hirschberg H, Slettebø H, Watne K, Nome O. High incidence of serious side effects of high-dose dexamethasone treatment in patients with epidural spinal cord compression. J Neurooncol 1992;12:141-4. doi:10.1007/BF00172664 pmid:1560260.
22 Royal College of Radiologists. Radiotherapy dose-fractionation. 2006. www.rcr.ac.uk/sites/default/files/publication/Dose-Fractionation_Final.pdf.
23 Maranzano E, Latini P, Beneventi S, et al. Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial. Am J Clin Oncol 1996;19:179-83. doi:10.1097/00000421-199604000-00018 pmid:8610645.
24 Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005;366:643-8. doi:10.1016/S0140-6736(05)66954-1 pmid:16112300.
25 Aoude A, Amiot L-P. A comparison of the modified Tokuhashi and Tomita scores in determining prognosis for patients afflicted with spinal metastasis. Can J Surg 2014;57:188-93. doi:10.1503/cjs.012013 pmid:24869611.
26 Fourney DR, Frangou EM, Ryken TC, et al. Spinal instability neoplastic score: an analysis of reliability and validity from the spine oncology study group. J Clin Oncol 2011;29:3072-7.doi:10.1200/JCO.2010.34.3897 pmid:21709187.
27 Fan Y, Zhou X, Wang H, et al. The timing of surgical intervention in the treatment of complete motor paralysis in patients with spinal metastasis. Eur Spine J 2016. doi:10. 1007/s00586-016-4406-7 pmid:26831534.
28 Harris M. Quality of life in patients with malignant spinal cord compression: a review of evidence-based literature. Int J Palliat Nurs 2016;22:37-43. doi:10.12968/ijpn.2016.22.1.37 pmid:26804955.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024